Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsInterest & Investment IncomeNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to -$0.38.

  • Roivant Sciences' EPS (Basic) fell 26521.74% to -$0.38 in Q4 2025 from the same period last year, while for Dec 2025 it was -$0.65, marking a year-over-year decrease of 11001.54%. This contributed to the annual value of $0.51 for FY2025, which is 9135.37% down from last year.
  • According to the latest figures from Q4 2025, Roivant Sciences' EPS (Basic) is -$0.38, which was down 26521.74% from -$0.17 recorded in Q3 2025.
  • Roivant Sciences' 5-year EPS (Basic) high stood at $6.44 for Q4 2023, and its period low was -$0.49 during Q4 2022.
  • Its 5-year average for EPS (Basic) is $0.17, with a median of -$0.33 in 2025.
  • As far as peak fluctuations go, Roivant Sciences' EPS (Basic) tumbled by 55000.0% in 2021, and later surged by 141428.57% in 2023.
  • Over the past 5 years, Roivant Sciences' EPS (Basic) (Quarter) stood at -$0.41 in 2021, then decreased by 19.51% to -$0.49 in 2022, then surged by 1414.29% to $6.44 in 2023, then tumbled by 96.43% to $0.23 in 2024, then plummeted by 265.22% to -$0.38 in 2025.
  • Its last three reported values are -$0.38 in Q4 2025, -$0.17 for Q3 2025, and -$0.33 during Q2 2025.